Background
==========

The GreA protein is an evolutionarily-conserved bacterial transcriptional factor, which interacts directly with RNA polymerase. Binding of GreA to paused and backtracked transcriptional complexes induces RNA polymerase to hydrolyze the last few nucleotide residues at the 3\' end of the nascent transcript protruding beyond the enzyme\'s catalytic center, and resume transcription, in vitro \[[@B1]\] and in vivo \[[@B2],[@B3]\]. The extensively characterized interaction between RNA polymerase and GreA leads most simply to the idea that GreA functions in transcriptional regulation. Consistent with this idea, *E. coli*lacking GreA protein exhibits altered levels of expression of some of its genes \[[@B4],[@B5]\], as well as of the transcript encoding bacteriophage λ proteins which are synthesized late in infection \[[@B6]\]. However, the magnitude of the gene expression effects is small, and a clear understanding of GreA\'s biological function remains to be obtained. Some recent studies have provided evidence that GreA may have a role in resolving conflicts between replication and transcription \[[@B7],[@B8]\].

In this study, *greA*mutants are shown to have effects on homologous recombination which can be most readily explained by a replication fork-preserving function of wild type GreA. These mutants were isolated in a screen for host functions which affect the cell\'s interaction with the Redβ recombination protein of bacteriophage λ.

In wild-type *E. coli*, homologous recombination depends primarily on the function of two proteins, the RecA synaptase and the RecBCD helicase/nuclease. For genetic engineering purposes, RecBCD is often replaced by the Red recombination system of bacteriophage λ \[[@B9]\]. The Red system, consisting of the single-strand annealing protein Redβ and the exonuclease λExo, can substitute for RecBCD in promoting RecA-dependent homologous recombination \[[@B10],[@B11]\]. In addition, however, Red confers new capabilities on the cell, including the ability of the cell\'s chromosome to recombine with short linear DNA species, even in the absence of RecA \[[@B12],[@B13]\]. In this RecA-independent mode of recombination, Red apparently acts by targeting the replisome, leading to either strand assimilation or a template switch \[[@B14],[@B15]\].

Results
=======

To probe interactions between the Red system and cellular proteins, Redβ was fused at its C-terminus to the SPA affinity tag \[[@B16]\] on a medium copy number plasmid, under control of the *lac*repressor. Redβ-SPA was found to be toxic, inhibiting the growth of wild type *E. coli*when induced. This toxicity is surprising, because Redβ itself is innocuous, and hundreds of non-toxic SPA-tagged *E. coli*proteins have been made and characterized \[[@B17]\]. One possible explanation is that the synthetic toxicity of Redβ-SPA results from the delivery of the SPA tag to a critical site, possibly the normal site of Redβ action in the cell. As a hypothetical example, if Redβ normally binds to a replisome protein, it would necessarily have evolved to do so without interfering with replication. However, Redβ with the 69 amino acid residue SPA tag appended might bind to its normal site and clash sterically with another component of the replisome. According to this reasoning, cellular mutants altered in their interaction with Redβ could be selected as suppressors of Redβ-SPA toxicity. Several such suppressor mutants were isolated. Initial mapping showed that three of the mutations mapped to the same area in the *E. coli*chromosome. Fine-structure mapping and sequencing revealed that these three mutants each encoded a GreA protein with a single amino acid substitution: D41N (isolated twice), or E44K. The affected residues are particularly significant in GreA\'s activity. Both participate in the coordination of Mg^++^ions in the catalytic core of RNA polymerase \[[@B18]-[@B20]\]. The *greA*-D41N mutation was found not to affect the level of either Redβ-SPA or Redβ as detected by western blot (not shown), ruling out the simplest explanation\--that the *greA*mutants suppress the toxicity of Redβ-SPA by preventing its synthesis.

To study the unexpected relationship between GreA and Red, *E. coli*strains were constructed bearing the *greA*D41N and E44K mutations, as well as a D41A mutation and a simple *greA*deletion, in a variety of genetic backgrounds. The strains were found to have a number of recombination-related phenotypes.

Consistent with the idea that the *greA*mutants might be affected in their interaction with Red, λ behaves as if it had a mutation in either *red*gene (*bet*or *exo*), or both, when infecting these mutant bacteria. A λ *red gam*double mutant does not form plaques on a *recA*host, though *red*and *gam*single mutants do so \[[@B21]\]. As indicated in Table [1](#T1){ref-type="table"}, a λ *gam*single mutant fails to form plaques on a *recA*host when the *recA*host additionally bears a *greA*point mutation (but not a *greA*deletion). A deletion eliminating both *red*genes reduces λ plaque size; similarly, the *greA*point mutations in the host reduce the size of wild type λ plaques. As might be expected if mutating either *red*or *greA*is equivalent in this test, the *greA*point mutations have less effect on the plaque size of a λ *red*mutant than on the plaque size of λ wild type. This latter observation suggests that the *greA*point mutation primarily affects λ *red*function, rather than λ transcription, but does not rule out the possibility that there might be some effect on transcription.

###### 

λ plaque formation^a^

  Host genotype^b^    λ wild   λ *gam*   λ *red*
  ------------------- -------- --------- ---------
  wild type           ++       \+        \+
                                         
  *greA-D41N*         \+       \-        \+
                                         
  *greA-D41A*         \+       \-        \+
                                         
  *greA-E44K*         \+       \-        \+
                                         
  *greAΔ*             ++       \+        \+
                                         
  *greBΔ*             ++       \+        \+
                                         
  *greBΔ greA-D41N*   \+       \-        \+

a\. ++ large plaques, + small plaques, - no plaques

b\. All strains bear a *recAΔtet*substitution.

The effects of *greA*mutants on λ recombination were tested more directly in a marker rescue test, shown in Figure [1](#F1){ref-type="fig"}. The crosses were done in a *recA*host, to restrict recombination to the Red-promoted, replisome invasion pathway \[[@B15]\]. Marker rescue was reduced 3-4 fold by the D41N and E44K substitutions, 2-fold by D41A, and very slightly by the *greA*deletion. The effects of the *greA*mutations on Red-mediated recombination are modest compared to the effects of a *red*deletion mutant, which reduces plaque formation in this test to the background of reversion, approximately 40-fold (data not shown).

![**Marker rescue**. A. λ *cI857 R-am5*, bearing an amber mutation in the endolysin gene R, can form a plaque on the non-suppressing host only if it recombines with the plasmid or reverts. B. Efficiencies of mutants relative to wild type. Titers of the phage on cells bearing the homology-containing plasmid, minus titers on cells bearing the vector (revertants) are determined, and divided by the wild type value. Means and standard errors of four experiments are shown. All strains are *recA*.](1471-2199-12-12-1){#F1}

The *greA*mutations also affect Red-mediated recombination outside the context of a phage infection. As shown in Figure [2](#F2){ref-type="fig"}, the efficiency of recombination between the bacterial chromosome and a linear dsDNA introduced by electroporation is reduced in the *greA*mutants, which exhibit the same rank order of effects as in the marker rescue experiment.

![**Red-mediated chromosomal gene replacement**. A. Strains bearing an alteration of the *lac*locus in which *lacI*through the N-terminal coding region of *lacZ*is replaced by the C-terminal two-thirds of the *bla*gene and the *aph*gene of Tn903 can recombine with a linear dsDNA generated by PCR and introduced by electroporation, creating an ampicillin-resistant, Lac+ recombinant. B. Efficiencies of mutant strains relative to wild type. Means and standard errors of three or four experiments are shown.](1471-2199-12-12-2){#F2}

Recombination via the RecA-RecBCD pathway is also affected by *greA*mutations. P1 transduction of the Tn*10 tetRA*genes inserted into several different locations in the chromosome was tested in the D41N mutant. In most, but not all cases, the mutant gave rise to more transductants than the wild type. A marker consisting of the *metB*gene replaced by *tetRA*was typical. As shown in Figure [3](#F3){ref-type="fig"}, the efficiency of transduction of *metBΔtet*is elevated by all the *greA*mutations. Again, the rank order of effects is the same, though in the opposite direction. The elevated frequency of transduction in the *greA*mutants could be attributed to an elevated frequency of recombination, rather than to a greater efficiency of P1 infection or *tetRA*expression, because P1 transduction of *tetRA*at some other loci, for example *proAB*or *recA*, was not elevated (data not shown).

![**Transduction**. Strains were infected with an amount of a P1 lysate grown on a *metBΔtet*strain sufficient to generate 50-100 transductants in the wild type. Ratios of mutant transductants to wild type transductants were calculated. Means and standard errors of 3-8 crosses are shown. A. RecBCD+ strains. B. Strains in which *recBCD*is replaced by *red*.](1471-2199-12-12-3){#F3}

To characterize further the specificity of *greA*recombination effects, the effect of the *greA*-D41N mutation on RecA-mediated recombination was tested in a strain in which *recBCD*was replaced by *red*. As shown in Figure [3](#F3){ref-type="fig"}, the replacement has little effect, in either a GreA+ or a *greA*-D41N background. In particular, the *greA*mutation stimulates RecA-Red recombination at least as much as it stimulates RecA-RecBCD recombination.

The GreB protein of *E. coli*is very similar to GreA in structure and biochemical activities \[[@B22]\]. The transcriptional effects of a *greA*deletion mutant are often greater in a strain in which *greB*is deleted as well \[[@B23],[@B6],[@B5],[@B8]\]. However, as shown in Table [1](#T1){ref-type="table"} and Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [3](#F3){ref-type="fig"}, deletion of *greB*had little or no effect on recombination, either by itself or in combination with *greA*-D41N.

The DksA protein of *E. coli*, compared to GreB, is more distantly related to GreA, but it shares a number of structural and mechanistic features with the Gre proteins, including an acid-tipped coiled coil which reaches into the secondary channel of RNA polymerase to regulate transcription \[[@B24],[@B25]\]. Chromosomal *dksA*mutants corresponding to the *greA*mutants described above were constructed and tested for recombination phenotypes: a deletion fusing the first three and last three codons, and a double substitution mutation neutralizing both of the acid fingertip residues, D71N/D74N \[[@B24],[@B26]\]. In contrast to the *greA*mutants, neither *dksA*mutant exhibited either depressed or elevated levels of Red-mediated or RecA-RecBCD-mediated recombination, nor was either resistant to Redβ-SPA (data not shown).

The mechanism by which the *greA*point mutations suppress Redβ-SPA toxicity was investigated by means of a complementation test. Wild type, D41N, and E44K alleles of *greA*, under control of their own promoters, were cloned in multicopy plasmids which are compatible with the Redβ-SPA expressing plasmids. The wild type *greA*plasmid was found to restore Redβ-SPA sensitivity to a chromosomal *greA*-D41N mutant, indicating that the suppression of Redβ-SPA toxicity does not result from a gain of function by the mutant GreA protein. Consistent with this conclusion, and more remarkably, the mutant plasmids do not confer Redβ-SPA resistance upon wild type *E. coli*, indicating that the wild type phenotype prevails even when the mutant gene has a higher copy number. However, interpretation of this latter result is complicated because the mutant plasmids significantly slow the growth of wild type cells, as expected based on the known toxicity of the mutant GreA proteins expressed at high levels \[[@B18]\].

The known biochemical properties of GreA substitution mutants suggest that one effect of the D41N or E44K mutation would be to increase the amount of time RNA polymerase spends stalled in certain backtracked transcriptional complexes. In the mutant, it is likely that other cellular proteins which respond to stalled transcriptional complexes will play a greater role in resolving them. One such protein is Mfd, which not only dissociates stalled transcription complexes, but at the same time recruits proteins that repair DNA lesions \[[@B27]\]. This line of reasoning leads to the question of whether mutant GreA suppression of Redβ-SPA toxicity is mediated by Mfd. Accordingly, wild type and *greA*-D41N strains lacking the *mfd*gene were constructed. Deletion of *mfd*was found to have no effect on either the Redβ-SPA resistance of the D41N mutant, or the Redβ-SPA sensitivity of wild type. It can be concluded that Mfd is not required for *greA*-D41N suppression of Redβ-SPA toxicity.

Discussion and Conclusions
==========================

The experiments described here show that *E. coli greA*mutants exhibit elevated levels of RecA-mediated recombination, and depressed levels of Red-mediated, RecA-independent recombination. GreA is a transcription factor, so these differing effects could be due to changes in gene expression, but recombination and DNA metabolism functions are not among the genes identified as significantly up- or down-regulated in a *greA*null mutant \[[@B5]\]. A more likely explanation comes from the idea that GreA functions to prevent stalling of replication forks that run into conflicts with transcription complexes \[[@B7],[@B8]\].

Replication in *E.coli*is highly processive, and maintains this processivity despite the presence on the template DNA of transcription complexes which have an intrinsic ability to stall replication forks \[[@B28]\]. Stalled replication forks are a potentially dangerous source of genetic instability, because they generate double-strand breaks through a process of RuvABC-mediated reversal and cleavage \[[@B29]\]. The dsDNA ends resulting from these breaks are recombinogenic \[[@B30]\], so loss of a function which promotes the progression of replication forks is predicted to stimulate RecA-RecBCD and RecA-Red recombination events, which proceed via mechanisms that are largely replication-independent \[[@B31]\]. Red-mediated recombination in the absence of RecA, on the other hand, is itself strongly replication-dependent \[[@B15],[@B32]\], so loss of a function which promotes the progression of replication forks might be expected to diminish it.

The *greA*mutant phenotypes reported here are consistent with a model in which replication forks stall either more frequently or for a longer time in a cell in which GreA is inactive. Replication processivity in the mutant then becomes dependent upon other transcription-replication mediators. A functionally defective GreA protein, such as D41N or E44K, which can still bind to its normal site on RNA polymerase, might have an exacerbated effect, by competing with one or more of the other mediators.

Two recent studies present evidence for a role of GreA in promoting the progression of replication forks. (1) Deletion of *greA*increases the UV sensitivity of a *ruvC*mutant. This effect of the *greA*mutant is suppressed by the RNA polymerase open complex-destabilizing *rpoB*mutant H1244Q. The investigators also found that GreA and DksA together contribute to the viability of a *ruvC*strain. They interpreted their observations as indicating that these transcription factors act at DNA lesions to resolve conflicts between DNA replication and transcription \[[@B7]\]. (2) Cultures of an *E. coli dnaC-ts*mutant were synchronized by temperature shift, then, after replication initiation, treated with serine hydroxamate to induce amino acid starvation. The treated cells completed the round of replication they had started, but failed to do so if they lacked DksA, or if they lacked both GreA and GreB. The replication block could be eliminated by additional treatment with rifampicin, or by a DksA-bypassing mutation in *rpoB*, P546L, indicating that RNA polymerase was responsible for the replication block, and that the transcription factors affected replication through their well-characterized interaction with RNA polymerase. The replication deficiency of the *dksA*mutant in this experiment could be complemented by overexpression of GreA from a plasmid. In synchronized *dnaC*mutant cells that were not treated with serine hydroxamate, deletion of *dksA*slightly reduced the rate of replication fork progression; deletion of *dksA*, *greA*, and *greB*all together substantially reduced it. \[[@B8]\]. To these two lines of evidence, a third is now added: in otherwise wild type cells, not treated with DNA damaging agents or metabolic inhibitors, *greA*mutations stimulate replication-independent recombination, and depress replication-dependent recombination.

Stimulation of replication-independent, RecA-RecBCD-mediated recombination was not uniform, but rather was found to vary among different loci. This observation is consistent with the idea that the stimulation is due to the production of dsDNA ends as a byproduct of replication-transcription conflicts: such conflicts would not be expected to occur at a uniform frequency around the chromosome, because different loci are transcribed at different rates.

Alteration of either of GreA\'s key active site residues has stronger recombination effects than simply eliminating GreA. This observation is consistent with previous studies of many GreA mutants, including D41N and D41A as well as other substitutions for both D41 and E44. These mutants generally reduce or eliminate GreA-induced transcript cleavage, but not binding to RNA polymerase \[[@B18]-[@B20]\]. Unlike wild type GreA, the mutant proteins inhibit elongation when used at high concentration in vitro \[[@B18]\]. One unexplained observation of the present study is that the D41A substitution was found to have smaller effects on recombination than the D41N substitution, whereas Laptenko et al. \[[@B18]\] found little if any difference in biochemical activities between these two mutants.

Wang and coworkers propose that the various transcription-replication mediators, including DksA, GreA, GreB and Mfd, could be specialized to prevent transcription-replication conflict under different conditions \[[@B8]\]. The experiments described here provide additional support for this interpretation: based on the recombination and Redβ-SPA sensitivity phenotypes, among these proteins, only GreA appears to have a significant role in mediating transcription-replication conflicts that arise during rapid growth in rich medium. Some qualitative observations on the growth properties of *greA*and *dksA*mutants are also consistent with this idea. The *greA*point mutants grow noticeably more slowly than either wild type or the *greA*deletion on rich medium (LB), but about as well as wild type on minimal medium (M9 glucose-thiamine). In contrast, the *dksA*D71N/D74N mutant grows about as well as wild type on LB, but only a little better on M9 glucose-thiamine than the *dksA*deletion mutant, which, as previously reported, grows very poorly on minimal medium \[[@B33]\].

Methods
=======

Strain construction
-------------------

Redβ was fused to the SPA affinity tag as described by Zeghouf et al. \[[@B16]\], on plasmid pKM208 \[[@B34]\]. The resulting plasmid, pTP1205, contains the *lacI*gene, a synthetic operon in which λ *gam*and *redβ-SPA*are transcribed from *Ptac*, and genes conferring resistance to ampicillin *(bla)*and kanamycin (*neo*). A derivative, pTP1206, was made by deleting *bla*. Further plasmid construction details are given in Table [2](#T2){ref-type="table"}. The growth of wild type *E. coli*bearing pTP1205 or pTP1206, but not pKM208, is inhibited by addition of the inducer isopropyl-β-D-thiogalactoside (IPTG). For selection of Redβ-SPA-resistant mutants, the reduced-genome *E. coli*strain MDS12 \[[@B35]\] was mutagenized with *N*-methyl-*N\'*-nitro-*N*-nitrosoguanidine plus chloramphenicol \[[@B36]\]. Plasmid pTP1206 was introduced into the mutagenized cells by electroporation. Kanamycin- and IPTG-resistant colonies were selected, and then screened, or re-selected, for the ability to grow while bearing pTP1205 in the presence of IPTG.

###### 

Plasmids

  pCP20                 \[[@B45]\]. Temperature-sensitive, with heat-inducible FLP
  --------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  pKM208                \[[@B34]\]. bla-Ptac-gam-bet-exo-lacI, temperature-sensitive mutant pSC101 origin
                        
  pJL148                \[[@B16]\]. SPA-neo
                        
  pTP1068               Plasmid containing bla-P~32~-aacC. See the description of pTP1232 below.
                        
  pTP1205               pKM208 × SP01,02 pcr of pJL148. The Red-mediated recombination event fuses the SPA tag to the C-terminal end of bet, deletes most of exo, and adds neo.
                        
  pTP1206               Deletion of bla from pTP1205 by digestion with PvuI and religation
                        
  pTP1214               pKM208 × cat29,30 pcr of Tn9 cat. The Red-mediated recombination event replaces a segment of pKM208 between lacI and the replication origin with the cat gene, flanked by BamH1 sites.
                        
  pTP1215               Deletion of cat from pTP1214 by digestion with BamH1 and religation
                        
  pTP1216               pTP1215 × cat27,28 pcr of Tn9 cat. The Red-mediated recombination event replaces bla and the f1 replication origin with cat. Smaller, chloramphenicol resistance-conferring version of pKM208.
                        
  pTP1222               A segment of λ wild type DNA was amplified by SR2,3 pcr. The product was digested with BamH1 and XbaI, and ligated with a BamH1- and XbaI-ended plasmid segment consisting of the Tn903 aph gene and the pSC101 replication origin.
                        
  pTP1223               Deletion of sequences between the EcoRV and XbaI sites of pTP1222. The resulting plasmid contains λ sequences from 45262 in the S gene to 45828 in the R gene.
                        
  pTP1228, 1230, 1231   Wild type, D41N, and E44K alleles of greA, respectively, amplified by PCR with primers greA5 and greA6, and cloned between the EcoR1 and BamH1 sites of a derivative of pBR322 lacking the sequences between the BamH1 and PvuII sites.
                        
  pTP1232               Contains the sequences used to construct TP1234, DNA from which in turn was used as the template for PCR synthesis of the 587-bp dsDNA used in the tests of Red-mediated chromosomal gene replacement (sequence shown in Figure [4](#F4){ref-type="fig"}). It includes the bla gene of pBR322, the synthetic, unregulated promoter P~32~(closely related to CP32 \[[@B46]\]), the lacZ ribosome binding site, and the N-terminal end of lacZ.

Mapping of the Redβ-SPA-resistant mutants was done as described by Ortenberg et al. \[[@B37]\], except that the mini transposon conferred resistance to tetracycline instead of chloramphenicol. Each mutant was infected with λNK1098 to generate a population with random tetracycline-resistant transposon insertions. Lysates of phage P1 grown on the populations were used to transduce wild type cells to tetracycline- and Redβ-SPA-resistance simultaneously. The mutation-linked transposons were then located by the use of arbitrary PCR and sequencing; oligonucleotides used for this purpose are described in Table [3](#T3){ref-type="table"}. The three *greA*mutants were first localized to the vicinity of *yrbD*and *yrbC*. An *argG::cat*insertion was then constructed, and three-factor crosses were employed to determine that the location of the mutations was between *argG*and *yrbD*(91% and 86% co-transduction, respectively). Sequencing of the region revealed that the three mutants had base substitutions altering *greA*codons 41 (GAC to AAC, D41N, isolated twice independently) or 44 (GAA to AAA, E44K), among other, uncorrelated mutations in nearby genes.

###### 

Oligos

  aof2       TCCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTTAGGTGGCGGTACTTGGGT
  ---------- ------------------------------------------------------------------------
  ARB1^a^    GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
             
  ARB2^a^    GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC
             
  ARB6^a^    GGCCACGCGTCGACTAGTAC
             
  bpa        TCTGGTGGCCGGAAGGCGAAGCGGCATGCATTTACGTTGAGGTCTGACAGTTACCAATGC
             
  BLZ3       GAACTTTAAAAGTGCTCATCATTG
             
  BLZ4       GGGTTTTCCCAGTCACG
             
  cat27      TCGGAGATCCCCCGGGCTGCAGGAATTCGATATCAAGCTTATGAGACGTTGATCGGCACG
             
  cat28      AGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTCAGGCGTAGCACCAGGC
             
  cat29      GACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGGATCCATGAGACGTTGATCGGCACG
             
  cat30      TGGCTAAATACGGAAGGATCTGAGGTTCTTATGGCTCTTGGATCCATTCAGGCGTAGCACCAGGC
             
  cat34      TCAAAATCGTCAACCCGATTATGGGCGTGAAATTCTGGGAATGAGACGTTGATCGGCACG
             
  cat35      GCGTACTGTGACTTCTTCTGCCGGGATCTTCACGCTCTCAATTCAGGCGTAGCACCAGGC
             
  cat38      AGGTTGATATTGATTCAGAGGTATAAAACGAATGAGTACTATGAGACGTTGATCGGCACG
             
  cat39      CCTACCCGGATATTATCGTGAGGATGCGTCATCGCCATTGATTCAGGCGTAGCACCAGGC
             
  cat40      CACCGTTACACATATGCAGGATGAAGCAGCCAACTTCCCGATGAGACGTTGATCGGCACG
             
  cat41      CGCAGTTCGAGGCTGAACTCTTCTTCCTGGGCTGCACGGTATTCAGGCGTAGCACCAGGC
             
  D41A       AGCTGCGTGGTATTCGGCGTTTTCTTTCAGGGCGCCATGCTCACGCGCTTCCGCGATAGCAGCAA
             
  D41N       AGCTGCGTGGTATTCGGCGTTTTCTTTCAGGTTGCCATGCTCACGCGCTTCCGCGATAGCAGCAA
             
  dksAD      AGTGCGTGTTAAGGAGAAGCAACATGCAAGAAATGGCTGGCTAATTACAGCCGTTCCATCACGT
             
  dksNN      CATATGCAGGATGAAGCAGCCAACTTCCCGAACCCGGTAAACCGTGCAGCCCAGGAAGAAGAGTTCAGCC
             
  E44K       CTGTTCACGAGCTGCGTGGTATTCGGCGTTTTTTTTCAGGTCGCCATGCTCACGCGCTTCCGCGA
             
  greA5      CATCATCATGAATTCAGCTGGTCAATCCGATGA
             
  greA6      ACTACTACTGGATCCTGTACAGGTCATCGGTAAAACG
             
  greA9      TGAAATCATTGCTGCTATCGCGGAAGCGCGTGAGCATGGCCTCGACATCTTGGTTACCGT
             
  greAD      ACATCTTGAGTATTGGGTAATTCTTACAGGTATTCAGCTTGCATTTGTTATACCTCTTGAATATTCCTGA
             
  greAX      CTGTTCACGAGCTGCGTGGTATTCGGCGTTTTCTTTCAGGCGCGGAATAACATCATTTGG
             
  greAY      GCTGCTATCGCGGAAGCGCGTGAGCATGGCGACCTGAAAGCTCGACATCTTGGTTACCGT
             
  greAZ      AGAAACCCTGCTGTTCACGAGCTGCGTGGTATTCGGCGTTCGCGGAATAACATCATTTGG
             
  PRO1       TGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTACAACCAATTAACCAATTCTG
             
  PRO2       GTCACGACGTTGTAAAACGACGGCCAGTGAATCCGTAATCACGTTGTGTCTCAAAATCTC
             
  Rtet1^a^   CCACTTAATGTGATCATTGAACC
             
  Rtet2^a^   AACCATTTTCAGTGATCCATTGC
             
  SP01       ATTCCTGAAACAGAAAGCCGCAGAGCAGAAGGTGGCAGCATCCATGGAAAAGAGAAG
             
  SP02       TTGCTCCCCAAATACAAAACCAATTTCAGCCAGTGCCTCGCATATGAATATCCTCCTTAG
             
  SR2        GACTACGACTACATCTAGATTCGAACATCGATATGGGCAACTCTATC
             
  SR3        ATCAGCCATCATGGATCCGTTTGCAATGGCGTACCTT

a\. Arbitrary PCR and sequencing to locate transposon insertions was done as described \[[@B47]\], but with primers designed for Tn10d(tet). The first round of PCR was done with primers Rtet1, ARB1, and ARB6; the second with Rtet2 and ARB2. Sequencing was done with Rtet2.

Mutations were introduced into the *greA*gene of *E. coli*strain MG1655 by the use of Red-mediated recombination, in a two-step process. The first two bases of codon 41 or 44 were replaced with a tetracycline-resistance cassette. Oligonucleotides were then used to delete the cassette and insert the new bases \[[@B9]\]. Recombinants were identified following kanamycin enrichment for tetracycline-sensitives; details of the protocol are given below. A deletion allele fusing the first three and last three codons of *greA*was constructed the same way. The *greA*alleles were verified by sequencing. The same processes were used to construct chromsomal *dksA*-D71N/D74K and *dksA*deletion mutants, except that the initial construction replaced ten bases in codons 71-74 with the *cat*gene. The *greB*mutation used in some of the experiments was introduced by P1 transduction as *greBΔkan-FRT*; the kanamycin resistance element in it was subsequently excised by the use of FLP recombinase as described \[[@B38]\]. The *mfd*gene was deleted the same way. Other genetic markers were introduced into *greA, greB*, or *dksA*mutant strains by P1 transduction. Further strain construction details are given in Table [4](#T4){ref-type="table"}.

###### 

Strains

  MG1655                                                                 Wild type                                                 \[[@B43]\]
  ---------------------------------------------------------------------- --------------------------------------------------------- -----------------------------------------
  MDS12                                                                  Reduced genome version of MG1655                          \[[@B35]\]
                                                                                                                                   
  JW1100                                                                 mfdΔkanFRT                                                \[[@B38]\]
                                                                                                                                   
  JW3369                                                                 greBΔkanFRT                                               \[[@B38]\]
                                                                                                                                   
  TP796                                                                  MDS12 recAΔtet                                            \[[@B44]\]
                                                                                                                                   
  TP798                                                                  MG1655 recBCDΔPtac-gam-bet-exo-cat                        \[[@B44]\]
                                                                                                                                   
  Strains constructed for this study. All are in the MG1655 background                                                             
                                                                                                                                   
  TP933                                                                  recBCDΔPtac-gam-bet-exo-cat lacIPΔ::bla-P~32~-aacC-lacZ   TP798 × bpa1,aof2 pcr of pTP1068
                                                                                                                                   
  TP965                                                                  recBCDΔPtac-gam-bet-exo-cat lacIPΔbla\'-kan-\'lacZ        TP933 × PRO1,2 pcr of Tn903 aph
                                                                                                                                   
  TP1195                                                                 greA::tet41                                               MG1655/pKM208 × greA9,X pcr of Tn10 tet
                                                                                                                                   
  TP1198                                                                 greA-D41N                                                 TP1195/pKM208 × oligo D41N
                                                                                                                                   
  TP1201                                                                 recAΔtet                                                  MG1655 × P1•TP796
                                                                                                                                   
  TP1202                                                                 greA-D41N recAΔtet                                        TP1198 × P1•TP796
                                                                                                                                   
  TP1203                                                                 greA::tet44                                               MG1655/pKM208 × greAY,Z pcr of Tn10
                                                                                                                                   
  TP1204                                                                 greA-D41A                                                 TP1195/pKM208 × oligo D41A
                                                                                                                                   
  TP1205                                                                 greAΔ                                                     TP1195/pKM208 × oligo greAD
                                                                                                                                   
  TP1208                                                                 greA-D41A recAΔtet                                        TP1204 × P1•TP796
                                                                                                                                   
  TP1209                                                                 greAΔ recAΔtet                                            TP1205 × P1•TP796
                                                                                                                                   
  TP1213                                                                 greAΔ greBΔtet                                            TP1205 × P1•TP1199
                                                                                                                                   
  TP1216                                                                 greA-E44K                                                 TP1203/pKM208 × oligo E44K
                                                                                                                                   
  TP1218                                                                 greBΔkanFRT                                               MG1655 × P1•JW3369
                                                                                                                                   
  TP1219                                                                 greA-E44K recAΔtet                                        TP1216 × P1•TP796
                                                                                                                                   
  TP1220                                                                 greA-E44K greBΔtet                                        TP1216 × P1•TP1199
                                                                                                                                   
  TP1222                                                                 greBΔFRT                                                  TP1218/pCP20 passaged at 42°
                                                                                                                                   
  TP1224                                                                 greA-D41N greBΔkanFRT                                     TP1198 × P1• JW3369
                                                                                                                                   
  TP1225                                                                 lacIPΔbla\'-kan-\'lacZ                                    MG1655 × P1•TP965
                                                                                                                                   
  TP1226                                                                 greA-D41N lacIPΔbla\'-kan-\'lacZ                          TP1198 × P1•TP965
                                                                                                                                   
  TP1227                                                                 greA-D41A lacIPΔbla\'-kan-\'lacZ                          TP1204 × P1•TP965
                                                                                                                                   
  TP1229                                                                 greA-E44K lacIPΔbla\'-kan-\'lacZ                          TP1216 × P1•TP965
                                                                                                                                   
  TP1230                                                                 recBCDΔred-cat greA-D41N                                  TP1198 × P1•TP798
                                                                                                                                   
  TP1231                                                                 greA-D41N greBΔFRT                                        TP1224/pCP20 passaged at 41°
                                                                                                                                   
  TP1232                                                                 greBΔFRT lacIPΔbla\'-kan-\'lacZ                           TP1222 × P1•TP965
                                                                                                                                   
  TP1233                                                                 greA-D41N greBΔFRT lacIPΔbla\'-kan-\'lacZ                 TP1231 × P1•TP965
                                                                                                                                   
  TP1234                                                                 lacIPΔ::bla-P~32~                                         TP1225/pTP1216 × pTP1232 linear
                                                                                                                                   
  TP1235                                                                 greBΔFRT recAΔtet                                         TP1222 × P1•TP796
                                                                                                                                   
  TP1236                                                                 greA-D41N greBΔFRT recAΔtet                               TP1231 × P1•TP796
                                                                                                                                   
  TP1241                                                                 greAΔcat lacIPΔbla\'-kan-\'lacZ                           TP1193 × P1•TP965
                                                                                                                                   
  TP1242                                                                 greAΔ lacIPΔbla\'-kan-\'lacZ                              TP1205 × P1•TP965
                                                                                                                                   
  TP1252                                                                 mfdΔkanFRT                                                MG1655 × P1•JW1100
                                                                                                                                   
  TP1253                                                                 greA-D41N mfdΔkanFRT                                      TP1198 × P1•JW1100
                                                                                                                                   
  TP1254                                                                 greA-E44K mfdΔkanFRT                                      TP1216 × P1•JW1100
                                                                                                                                   
  TP1255                                                                 dksAΔ10::cat                                              MG1655/pKM208 × cat40,41 pcr of Tn9
                                                                                                                                   
  TP1257                                                                 mfdΔFRT                                                   TP1252/pCP20 passaged at 41°
                                                                                                                                   
  TP1258                                                                 greA-D41N mfdΔFRT                                         TP1253/pCP20 passaged at 41°
                                                                                                                                   
  TP1259                                                                 greA-E44K mfdΔFRT                                         TP1254/pCP20 passaged at 41°
                                                                                                                                   
  TP1260                                                                 dksA-D71N/D74N                                            TP1255/pKM208 × oligo dksNN
                                                                                                                                   
  TP1262                                                                 dksA-D71N/D74N recAΔtet                                   TP1262 × P1•TP796
                                                                                                                                   
  TP1263                                                                 dksAΔ                                                     TP1255/pKM208 × oligo dksAD
                                                                                                                                   
  TP1264                                                                 dksAΔ recAΔtet                                            TP1263 × P1•TP796

Kanamycin enrichment for chloramphenicol-sensitive or tetracycline-sensitive variants
-------------------------------------------------------------------------------------

Following electroporation, bacteria were diluted into 15 ml of LB, and left standing overnight at 30°C for complete recovery from electroporation and outgrowth of fully sensitive recombinants. 0.2 ml of the culture was diluted into 5 ml LB and aerated at 37°C until a density of about 7 × 10^7^/ml was reached. At that point, 2.5 ml of culture was mixed with 2.5 ml LB plus 100 μl of either chloramphenicol at 1 mg/ml or tetracycline at 0.4 mg/ml, and aerated at 37°C for 40 min. At that time, 2 ml of culture was mixed with 2 ml LB plus 40 μl chloramphenicol or tetracycline, plus 4 μl kanamycin at 20 mg/ml (for a final kanamycin concentration of 20 μg/ml), and aerated at 37°C for 40 min, then left standing overnight at room temperature. Portions of the culture were plated on LB, and the resulting colonies were tested for chloramphenicol or tetracycline sensitivity. Clones bearing the intended deletion were identified by the use of PCR and sequencing.

Phages
------

λNK1098 bears the mutations cI857 and P-am80, as well as a mini Tn10 tet element and the Tn10 transposase fused to Ptac. It is similar to λNK1323 \[[@B39]\], but its transposase is wild type, rather than the Altered Target Specificity double mutant version borne by λNK1323. The amber mutation R5 \[[@B40]\], used in marker rescue experiments, was sequenced and found to change λ 45710 from G-C to A-T, which turns R codon 73, UGG, into UAG. The γ210 mutation \[[@B21]\], used in plating tests, was sequenced and found to change λ 33076 from G-C to A-T, which turns *gam*codon 53, CAG, into UAG. The deletion-substitution mutation *redΔcat*, used in plating tests, was constructed by the use of Red-mediated recombination \[[@B41]\], with a dsDNA made by PCR amplification of Tn9 *cat*with oligo primers cat38 and cat39 (Table [3](#T3){ref-type="table"}). The deletion-substitution leaves in place the first three codons of *bet*and the last three codons of *exo*.

Gene-replacement recombination test
-----------------------------------

Strains to be tested for Red-mediated chromosomal gene replacement were transformed with plasmid pTP1216, a derivative of pKM208 in which *bla*is replaced by *cat*. They were grown at 30°C in LB broth supplemented with chloramphenicol at 20 μg/ml, induced with 1 mM IPTG, and prepared for electroporation as described by Murphy and Campellone \[[@B34]\]. Cells were electroporated with a mixture of 150 ng of a dsDNA generated by PCR of plasmid pTP1232 (Table [2](#T2){ref-type="table"}) with oligo primers BLZ3 and BLZ4 (Table [3](#T3){ref-type="table"}), plus 1 ng of plasmid pMB9 \[[@B42]\]. The linear dsDNA was 587 bp, including 50 bp homology-targeting flanks (Figure [4](#F4){ref-type="fig"}). Following electroporation, the cells were diluted into 3 ml LB broth, grown with aeration for 2 hr at 37°C, and plated at 37°C on LB agar supplemented with ampicillin at 100 μg/ml, or tetracycline at 15 μg/ml. To adjust for variable growth rates and electroporation efficiencies, the ratio of ampicillin-resistant (recombinant) to tetracycline-resistant (transformant) colonies, normalized to that of the wild type control, was used as a measure of relative recombination proficiency.

![**Sequence of the 587-bp dsDNA used in the tests of Red-mediated chromosomal gene replacement**. The first and last 50 bases are the homology flanks. Bases in bold type are, in order, the start codon of bla (reverse complement), the -35 and -10 hexamers of P~32~, and lacZ ribosome binding site.](1471-2199-12-12-4){#F4}
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